InvestorsHub Logo

Danielson555

04/08/19 8:18 AM

#49718 RE: mycherio #49715

It is a reasonable question as to whether Ww has been making money at shareholder expense in buying the labs at such high prices. And in Colorado absolutely no money from that lab goes to Evio. Then why pay all that money when you're hungry for revenue? Mass. Lab purchase also for over 1MM for a one year old shelf company unlicensed and uncertified, also purchased by Lusardi. High prices, hidden compensation for Ww, and no revenue from Colorado lab to Evio. ZERO.

Please someone prove me wrong. I want to be wrong. But the purchasing of these expensive labs is so weird.

Deviant billing. That's when a company reduces taxable income by siphoning off revenue to other entities that serve as suppliers, vendors, or fake branches of the company that produce nothing. Revenue is diverted from the balance statement and the funds are controlled through nominees for personal enrichment. I am not sure that's happening here. But I keep coming back to this. Mentioned it before. It's because maybe the timing is right for people to notice that something is amiss. My concern was discarded as crazy before. Maybe now someone will agree to review my concern. Perhaps call the Colorado lab and ask if any of their revenue goes into Evios coffers. They told me it was an R and D lab. So much investment for R and D when the company is struggling to get a lab online and starving for revenue. Same Lusardi common denominator. Call me crazy guys. It stinks to me in my own little conspiracy laden mind.